Topical Application of Chinese Formula Yeliangen Promotes Wound Healing in Streptozotocin-Induced Diabetic Rats
Open Access
- 29 November 2022
- journal article
- research article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2022, 1-14
Abstract
Diabetic wound is one of the most severe complications of diabetes mellitus (DM). Despite the associated risks of wound healing impairment in diabetes, treatment strategies remain limited. Yeliangen (YLG) is a Chinese formulation mainly composed of the rhizome of Coptis chinensis, the root of Isatis tinctoria, and the leaf of Isatis indigotica. We investigated the wound healing effects of YLG in type 2 diabetic (T2DM) rats, which were induced by intraperitoneal administration of streptozotocin after a high-fat diet for four weeks. full-thickness excisional wounds were created on the dorsal surface of rats and then divided to control (DC), negative (DPJ), positive (DPC), and YLG-treated (DYLG) groups. Rat’s wounds were treated twice daily for 21 days. Wound area and wound contraction were detected on days 0, 3, 7, 14, and 21. Histopathological examinations were performed by H&E staining and immunohistochemistry (IHC). The biochemical parameters, mRNAs, and protein expressions were analyzed through enzyme-linked immunoassays (ELISA), qPCR, and western blot, respectively. Compared with other groups, the histological changes of wound tissue in the DYLG group were improved, and the expressions of CD31, eNOS, and PCNA were significantly upregulated. Besides, YLG significantly reduced the inflammatory factors’ expressions of TNF-α, NF-κB, MMP-9, and IL-1B on days 7, 14, and 21 postwounding. Moreover, YLG induced angiogenesis and neovascularization by significantly increasing the levels of VEGF, TGF-β1, EGF, PDGF, and SDF-1α on days 3, 7, and 14. In conclusion, YLG improved wound healing by reducing inflammation and increasing angiogenesis which may provide an alternative and effective approach for diabetic wound therapy.Keywords
Funding Information
- Guangxi Health Commission Key Laboratory of Basic Research on Antigeriatric Drugs (2017GXNSFAA198304)
- Natural Science Foundation of Guangxi Province (2017GXNSFAA198304)
This publication has 46 references indexed in Scilit:
- Topical application of substance P promotes wound healing in streptozotocin-induced diabetic ratsCytokine, 2015
- Pharmacological effect of Ageratina pichinchensis on wound healing in diabetic rats and genotoxicity evaluationJournal of Ethnopharmacology, 2014
- Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in ratsChemico-Biological Interactions, 2014
- Cytokines and Diabetes ResearchJournal of Diabetes Research, 2014
- High-Glucose Environment Enhanced Oxidative Stress and Increased Interleukin-8 Secretion From KeratinocytesDiabetes, 2013
- Dual action of TGF-β induces vascular growth in vivo through recruitment of angiogenic VEGF-producing hematopoietic effector cellsAngiogenesis, 2012
- Impaired TGF-βsignaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetesMolecular BioSystems, 2011
- Effect of hyperglycemia and neuropeptides on interleukin-8 expression and angiogenesis in dermal microvascular endothelial cellsJournal of Vascular Surgery, 2011
- Wound healing and its impairment in the diabetic footThe Lancet, 2005
- Topical Vascular Endothelial Growth Factor Accelerates Diabetic Wound Healing through Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived CellsThe American Journal of Pathology, 2004